FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Integrated Cannabis Solutions, Inc. Stock AnalysisComprehensive stock analysis for Integrated Cannabis Solutions, Inc. (IGPK) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisIGPK
IGPK
Integrated Cannabis Solutions, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
IGPK
Home🔹Stocks🔹Integrated Cannabis Solutions, Inc.

Integrated Cannabis Solutions, Inc.

🇺🇸IGPK•OTC

Integrated Cannabis Solutions, Inc.

🇺🇸IGPK•OTC
Market cap
$1.35M
Sentiment

Your view on IGPK

Mkt Cap
$1.35M
Sentiment
Your view
IGPK
Integrated Cannabis Solutions, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
IGPK
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Integrated Cannabis Solutions, Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Eugene L. Caiazzo
Headquarters
6810 North State Road 7, Coconut Creek, FL, US
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Eugene L. Caiazzo
Headquarters
6810 North State Road 7, Coconut Creek, FL, US
Description

Integrated Cannabis Solutions, Inc. focuses on the growing and processing of hemp or biomass in the United States.

The company intends to sell processed material in the form of Cannabidiol (CBD) or isolate to manufacturers or pharmaceutical companies for their manufacture, distribution, and sale of CBD related products, such as edibles for human consumption, vitamins, multi-vitamins, and topical products for human use comprises oils, tinctures, creams, oils and salves, and vaping liquids.

Further, it is planning to promote and assist in the establishment of a co-op with local farmers for establishing a consistent supply of biomass and enter into long term purchase contracts. The company was formerly known as Integrated Parking Solutions, Inc. and changed its name to Integrated Cannabis Solutions, Inc. in April 2014.

Integrated Cannabis Solutions, Inc. was founded in 2003 and is headquartered in Coconut Creek, Florida.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Integrated Cannabis Solutions, Inc., and the rating behind it. IGPK last traded at $0.0008, 12.9× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Integrated Cannabis Solutions, Inc.. Starting points for Integrated Cannabis Solutions, Inc.: P/E 12.9, beta 0.01 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Integrated Cannabis Solutions, Inc.. Integrated Cannabis Solutions, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Integrated Cannabis Solutions, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Integrated Cannabis Solutions, Inc.. Integrated Cannabis Solutions, Inc. has reported as a listed company since 1997. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Integrated Cannabis Solutions, Inc. valued side by side against its closest peers. Integrated Cannabis Solutions, Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Integrated Cannabis Solutions, Inc., and how their positions are changing. At a $1.3M market value, institutional positions materially move Integrated Cannabis Solutions, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Integrated Cannabis Solutions, Inc. executives and directors. Shares of Integrated Cannabis Solutions, Inc. have traded between $0.0005 and $0.0083 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Integrated Cannabis Solutions, Inc.. Integrated Cannabis Solutions, Inc. is a $1.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Integrated Cannabis Solutions, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Integrated Cannabis Solutions, Inc.. Coverage tracks Integrated Cannabis Solutions, Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BIOE — Bio Essence Corporation
  • CPMD — CannaPharmaRX, Inc.
  • CRYM — Cryomass Technologies Inc.
  • IGEX — Indo Global Exchange(s) PTE, Ltd.
  • MCOA — Marijuana Company of America, Inc.
  • RDDTF — Radient Technologies Inc.
  • SHMN — SOHM, Inc.

More Drug Manufacturers - Specialty & Generic companies

  • AMRX — Amneal Pharmaceuticals, Inc.
  • ANIP — ANI Pharmaceuticals, Inc.
  • ANTCF — Aion Therapeutic Inc.
  • AOLS — Aeolus Pharmaceuticals, Inc.
  • APNHF — Aspen Pharmacare Holdings Limited
  • APNHY — Aspen Pharmacare Holdings Limited
  • APPB — Applied Biosciences Corp.
  • APTX.TO — Apotex Health Corp.
  • AQST — Aquestive Therapeutics, Inc.
  • AQSZF — Aequus Pharmaceuticals Inc.
  • ARSUF — Fagron N.V.
  • ARYX — ARYx Therapeutics, Inc.

News

Latest Market News